Loperamide hydrochloride structure 
             | 
        Common Name | Loperamide hydrochloride | ||
|---|---|---|---|---|
| CAS Number | 34552-83-5 | Molecular Weight | 513.498 | |
| Density | N/A | Boiling Point | 647.2ºC at 760 mmHg | |
| Molecular Formula | C29H34Cl2N2O2 | Melting Point | 223-225°C | |
| MSDS | Chinese USA | Flash Point | 345.2ºC | |
| Symbol | 
             
            
            GHS06  | 
        Signal Word | Danger | |
            Use of Loperamide hydrochlorideLoperamide hydrochloride is an opiate receptor agonist for the treatment of diarrhea.  | 
    
| Name | loperamide hydrochloride | 
|---|---|
| Synonym | More Synonyms | 
| Description | Loperamide hydrochloride is an opiate receptor agonist for the treatment of diarrhea. | 
|---|---|
| Related Catalog | |
| References | 
| Boiling Point | 647.2ºC at 760 mmHg | 
|---|---|
| Melting Point | 223-225°C | 
| Molecular Formula | C29H34Cl2N2O2 | 
| Molecular Weight | 513.498 | 
| Flash Point | 345.2ºC | 
| Exact Mass | 512.199707 | 
| PSA | 43.78000 | 
| LogP | 5.82790 | 
| Storage condition | Store at RT | 
                                    CHEMICAL IDENTIFICATION
 
 
 
 
 
 
 
 HEALTH HAZARD DATAACUTE TOXICITY DATA
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  | 
                            
| Symbol | 
                                    
                                     
                                    
                                    GHS06  | 
                            
|---|---|
| Signal Word | Danger | 
| Hazard Statements | H301 | 
| Precautionary Statements | P301 + P310 | 
| Personal Protective Equipment | Eyeshields;Faceshields;Gloves;type P2 (EN 143) respirator cartridges | 
| Hazard Codes | T:Toxic | 
| Risk Phrases | R25 | 
| Safety Phrases | S45 | 
| RIDADR | UN 2811 6.1/PG 3 | 
| WGK Germany | 3 | 
| RTECS | TM4960000 | 
| Packaging Group | III | 
| Hazard Class | 6.1(b) | 
| 
                                        
                                        
                                        
                                        
                                         ~67%  
                                            Loperamide hydr... CAS#:34552-83-5  | 
                                
| Literature: INSTITUT UNIVERSITARI DE CIENCIA I TECNOLOGIA Patent: WO2008/80601 A2, 2008 ; Location in patent: Page/Page column 10 ; | 
| 
                                        
                                        
                                        
                                        
                                         ~%  
                                            Loperamide hydr... CAS#:34552-83-5  | 
                                
| Literature: US5798093 A1, ; | 
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| 
                                    
                                    Salt effects in electromembrane extraction.
                                    
                                    
                                     J. Chromatogr. A. 1347 , 1-7, (2014) Electromembrane extraction (EME) was performed on samples containing substantial amounts of NaCl to investigate how the presence of salts affected the recovery, repeatability, and membrane current in ...  | 
                                |
| 
                                    
                                    Assessment of a candidate marker constituent predictive of a dietary substance-drug interaction: case study with grapefruit juice and CYP3A4 drug substrates.
                                    
                                    
                                     J. Pharmacol. Exp. Ther. 351(3) , 576-84, (2014) Dietary substances, including herbal products and citrus juices, can perpetrate interactions with conventional medications. Regulatory guidances for dietary substance-drug interaction assessment are l...  | 
                                |
| 
                                    
                                    Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity.
                                    
                                    
                                     J. Chromatogr. A. 1374 , 122-33, (2014) The present study investigated the practical use of modern ultra-high performance liquid chromatography (UHPLC) separation techniques for drug metabolite profiling, aiming to develop a widely applicab...  | 
                                
| 4-[4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride (1:1) | 
| Imosec | 
| 1-piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-a,a-diphenyl-, hydrochloride (1:1) | 
| Fortasec | 
| 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride | 
| LOPERAMIDE HCL | 
| LoperaMide Hydrochloride | 
| 4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide,hydrochloride | 
| 1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-α,α-diphenyl-, hydrochloride (1:1) | 
| Suprasec | 
| Dissenten | 
| MFCD00058581 | 
| arret | 
| 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride | 
| Lopemin | 
| 4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide hydrochloride (1:1) | 
| BREK | 
| EINECS 252-082-4 | 
| BLOX | 
| Lopemid | 
| Loperyl | 
| 4-[4-(4-Chlorphenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamidhydrochlorid | 
| 4-[4-(4-chlorophényl)-4-hydroxypipéridin-1-yl]-N,N-diméthyl-2,2-diphénylbutanamide chlorhydrate | 
| Imodium | 
| Tebloc | 
| Loperamide (hydrochloride) |